{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:14:05Z","timestamp":1790248445157,"version":"4.1.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI175699"],"award-info":[{"award-number":["R01AI175699"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI140287"],"award-info":[{"award-number":["R01AI140287"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Vancomycin ranks among the most utilized antimicrobial agents in the treatment of serious \u03b2-lactam\u2013resistant gram-positive infections, but its use has been associated with nephrotoxicity. Reduction of acute kidney injury (AKI) has been reported in preclinical models with adjuvant montelukast. The purpose of the study was to ascertain if montelukast was associated with a reduction in the prevalence of vancomycin-associated AKI.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This retrospective cohort study examined adult patients who received intravenous vancomycin between January 2020 and January 2024. The RIFLE criteria (risk, injury, failure, loss, and end-stage kidney disease) were employed in identifying cases of AKI. Additionally, a preclinical vancomycin-associated nephrotoxicity model was established to provide insights into possible renal protective mechanisms.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Patients receiving montelukast (n = 110) were compared with controls (n = 330), of which AKI was observed in 3 (2.7%) vs 35 (10.6%), respectively (P = .01). A multivariate logistic regression analysis revealed that weight (odds ratio [OR], 1.02; 95% CI, 1.006\u20131.03; P = .005) and intensive care unit admission (OR, 6.88; 95% CI, 2.96\u201318.8; P &amp;lt; .001) were independently associated with AKI, while montelukast (OR, 0.26; 95% CI, .06\u2013.77; P = .03) and male gender were protective (OR, 0.41; 95% CI, .19\u2013.85; P = .02). Our in vitro model also revealed that adjuvant montelukast can reduce injury to proximal tubule cells through activation of the p62\/KEAP-1\/HO-1 antioxidant pathway.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Our study suggests that montelukast during vancomycin therapy may be protective against AKI, which may reduce patient harm and hospitalization costs. Further studies are warranted to validate our findings prospectively.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/infdis\/jiaf027","type":"journal-article","created":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T23:15:34Z","timestamp":1736637334000},"page":"191-198","source":"Crossref","is-referenced-by-count":7,"title":["Reduction of Vancomycin-Associated Acute Kidney Injury With Montelukast"],"prefix":"10.1093","volume":"232","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7063-2191","authenticated-orcid":false,"given":"Nicholas S","family":"Teran","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice and Translational Research, College of Pharmacy, University of Houston"},{"name":"Department of Pharmacy, Baylor St Luke\u2019s Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0284-4261","authenticated-orcid":false,"given":"Cole S","family":"Hudson","sequence":"additional","affiliation":[{"name":"Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7118-0510","authenticated-orcid":false,"given":"Kady","family":"Phe","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Baylor St Luke\u2019s Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunting","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8338-3013","authenticated-orcid":false,"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7889-8023","authenticated-orcid":false,"given":"Hua","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Health Outcomes and Policy, College of Pharmacy, University of Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Nigo","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Houston Methodist Hospital, Texas Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7071-5376","authenticated-orcid":false,"given":"Vincent H","family":"Tam","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice and Translational Research, College of Pharmacy, University of Houston"},{"name":"Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"key":"2025073007430618700_jiaf027-B1","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","article-title":"Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists","volume":"77","author":"Rybak","year":"2020","journal-title":"Am J Health Syst Pharm"},{"key":"2025073007430618700_jiaf027-B2","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1128\/AAC.01568-12","article-title":"Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter","volume":"57","author":"van Hal","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2025073007430618700_jiaf027-B3","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1164\/rccm.201311-2097OC","article-title":"Small acute increases in serum creatinine are associated with decreased long-term survival in the critically ill","volume":"189","author":"Linder","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2025073007430618700_jiaf027-B4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s40121-019-00278-1","article-title":"A multicenter evaluation of vancomycin-associated acute kidney injury in hospitalized patients with acute bacterial skin and skin structure infections","volume":"9","author":"Jorgensen","year":"2020","journal-title":"Infect Dis Ther"},{"key":"2025073007430618700_jiaf027-B5","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1093\/cid\/ciz051","article-title":"Vancomycin area under the curve and acute kidney injury: a meta-analysis","volume":"69","author":"Aljefri","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2025073007430618700_jiaf027-B6","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/cpt.726","article-title":"The nephrotoxicity of vancomycin","volume":"102","author":"Filippone","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"2025073007430618700_jiaf027-B7","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/1071576031000061002","article-title":"Targeting superoxide dismutase to renal proximal tubule cells attenuates vancomycin-induced nephrotoxicity in rats","volume":"37","author":"Nishino","year":"2003","journal-title":"Free Radic Res"},{"key":"2025073007430618700_jiaf027-B8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkz325","article-title":"Mechanisms of antimicrobial-induced nephrotoxicity in children","volume":"75","author":"Downes","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"2025073007430618700_jiaf027-B9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.tox.2005.07.009","article-title":"In vivo evidences suggesting the role of oxidative stress in pathogenesis of vancomycin-induced nephrotoxicity: protection by erdosteine","volume":"215","author":"\u00d6ktem","year":"2005","journal-title":"Toxicology"},{"key":"2025073007430618700_jiaf027-B10","doi-asserted-by":"crossref","first-page":"436856","DOI":"10.4061\/2011\/436856","article-title":"Biopsy-proven acute tubular necrosis due to vancomycin toxicity","volume":"2011","author":"Shah-Khan","year":"2011","journal-title":"Int J Nephrol"},{"key":"2025073007430618700_jiaf027-B11","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/phar.2388","article-title":"Vancomycin-induced kidney injury: animal models of toxicodynamics, mechanisms of injury, human translation, and potential strategies for prevention","volume":"40","author":"Pais","year":"2020","journal-title":"Pharmacotherapy"},{"key":"2025073007430618700_jiaf027-B12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12882-018-0845-1","article-title":"Biopsy-proven vancomycin-induced acute kidney injury: a case report and literature review","volume":"19","author":"Sawada","year":"2018","journal-title":"BMC Nephrol"},{"key":"2025073007430618700_jiaf027-B13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1742-7843.2005.pto_153.x","article-title":"Protective effects of different antioxidants and amrinone on vancomycin-induced nephrotoxicity","volume":"97","author":"Celik","year":"2005","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2025073007430618700_jiaf027-B14","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJMra071371","article-title":"Leukotrienes","volume":"357","author":"Peters-Golden","year":"2007","journal-title":"N Engl J Med"},{"key":"2025073007430618700_jiaf027-B15","doi-asserted-by":"crossref","first-page":"e21979","DOI":"10.1002\/jbt.21979","article-title":"Renoprotective effects of montelukast in an experimental model of cisplatin nephrotoxicity in rats","volume":"31","author":"Gad","year":"2017","journal-title":"J Biochem Mol Toxicol"},{"key":"2025073007430618700_jiaf027-B16","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3109\/0886022X.2012.761040","article-title":"Protective effect of montelukast which is cysteinyl-leukotriene receptor antagonist on gentamicin-induced nephrotoxicity and oxidative damage in rat kidney","volume":"35","author":"Otunctemur","year":"2013","journal-title":"Ren Fail"},{"key":"2025073007430618700_jiaf027-B17","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1186\/cc2872","article-title":"Acute renal failure\u2014definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group","volume":"8","author":"Bellomo","year":"2004","journal-title":"Crit Care"},{"key":"2025073007430618700_jiaf027-B18","doi-asserted-by":"crossref","first-page":"106393","DOI":"10.1016\/j.biocel.2023.106393","article-title":"The endocytosis receptor megalin: from bench to bedside","volume":"157","author":"Goto","year":"2023","journal-title":"Int J Biochem Cell Biol"},{"key":"2025073007430618700_jiaf027-B19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejphar.2017.02.025","article-title":"Vancomycin induces reactive oxygen species\u2013dependent apoptosis via mitochondrial cardiolipin peroxidation in renal tubular epithelial cells","volume":"800","author":"Sakamoto","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"2025073007430618700_jiaf027-B20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.addr.2014.05.016","article-title":"Innovative approaches to optimizing the delivery of vancomycin in individual patients","volume":"77","author":"Pai","year":"2014","journal-title":"Adv Drug Deliv Rev"},{"key":"2025073007430618700_jiaf027-B21","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1200\/JCO.1996.14.7.2101","article-title":"Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer","volume":"14","author":"Kemp","year":"1996","journal-title":"J Clin Oncol"},{"key":"2025073007430618700_jiaf027-B22","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1200\/JCO.1996.14.12.3112","article-title":"Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy for advanced breast cancer","volume":"14","author":"Venturini","year":"1996","journal-title":"J Clin Oncol"},{"key":"2025073007430618700_jiaf027-B23","doi-asserted-by":"crossref","first-page":"e0046221","DOI":"10.1128\/AAC.00462-21","article-title":"Renoprotective effects of melatonin against vancomycin-related acute kidney injury in hospitalized patients: a retrospective cohort study","volume":"65","author":"Hong","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"2025073007430618700_jiaf027-B24","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jss.2008.08.006","article-title":"Protective potential of montelukast against hepatic ischemia\/reperfusion injury in rats","volume":"159","author":"\u00d6zkan","year":"2010","journal-title":"J Surg Res"},{"key":"2025073007430618700_jiaf027-B25","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1472-8206.2011.00996.x","article-title":"Montelukast ameliorates kidney function and urinary bladder sensitivity in experimentally induced renal dysfunction in rats","volume":"27","author":"Suddek","year":"2013","journal-title":"Fundam Clin Pharmacol"},{"key":"2025073007430618700_jiaf027-B26","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1128\/AAC.03970-14","article-title":"Association between vancomycin day 1 exposure profile and outcomes among patients with methicillin-resistant Staphylococcus aureus infective endocarditis","volume":"59","author":"Casapao","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2025073007430618700_jiaf027-B27","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.molcel.2013.08.003","article-title":"Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy","volume":"51","author":"Ichimura","year":"2013","journal-title":"Mol Cell"},{"key":"2025073007430618700_jiaf027-B28","doi-asserted-by":"crossref","first-page":"24131","DOI":"10.1074\/jbc.M702824200","article-title":"P62\/SQSTM1 binds directly to Atg8\/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy","volume":"282","author":"Pankiv","year":"2007","journal-title":"J Biol Chem"},{"key":"2025073007430618700_jiaf027-B29","doi-asserted-by":"crossref","first-page":"4513","DOI":"10.1096\/fj.201801515R","article-title":"Atg7 mediates renal tubular cell apoptosis in vancomycin nephrotoxicity through activation of PKC-\u03b4","volume":"33","author":"Xu","year":"2019","journal-title":"FASEB J"},{"key":"2025073007430618700_jiaf027-B30","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1021\/acs.jafc.7b04565","article-title":"Protective effects of DHA-PC against vancomycin-induced nephrotoxicity through the inhibition of oxidative stress and apoptosis in BALB\/c mice","volume":"66","author":"Shi","year":"2018","journal-title":"J Agric Food Chem"},{"key":"2025073007430618700_jiaf027-B31","doi-asserted-by":"crossref","first-page":"1156346","DOI":"10.3389\/fneph.2023.1156346","article-title":"The roles of heme oxygenase-1 in renal disease","volume":"3","author":"Zhai","year":"2023","journal-title":"Front Nephrol"},{"key":"2025073007430618700_jiaf027-B32","doi-asserted-by":"crossref","first-page":"F385","DOI":"10.1152\/ajprenal.00335.2015","article-title":"Proximal tubule-targeted heme oxygenase-1 in cisplatin-induced acute kidney injury","volume":"310","author":"Bolisetty","year":"2016","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiaf027\/61440306\/jiaf027.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/232\/1\/191\/61440306\/jiaf027.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/232\/1\/191\/61440306\/jiaf027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T11:43:20Z","timestamp":1753875800000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/232\/1\/191\/7954290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,15]]},"published-print":{"date-parts":[[2025,7,30]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiaf027","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7,15]]},"published":{"date-parts":[[2025,1,15]]}}}